Roche (JOBS) Says Still Commited to Genentech, Inc. (JOBS) Bid

November 25, 2008 |

1 min read

ZURICH, Nov 25 (Reuters) - Swiss drugmaker Roche Holding AG is still committed to a $43.7 billion bid to buy out U.S. biotech group Genentech Inc, a spokesman said on Tuesday.

Mergers & acquisitions Europe

Genentech, Inc. Roche

MORE ON THIS TOPIC

Business negotiation and cooperation vector concept. Symbol of a deal, handshake, success. Minimal design eps10 illustration.

Gene therapy

AviadoBio Looks to China for Eye-Based Gene Therapy in $413M UgeneX Pact

October 10, 2025

·

2 min read

·

Tristan Manalac

Illustration showing a handshake, signaling cooperation, goodwill

Mergers & Acquisitions

Novo Strikes up to $5.2B Deal for Akero in Red-Hot MASH Space

October 9, 2025

·

2 min read

·

Annalee Armstrong

Modern design with a positive context, a handshake. Concept of help, support and harmony between adults. Modern art collage, trendy magazine style.

Mergers & acquisitions

Zenas Bets $2B+ in Autoimmune Agreement With Chinese Firm InnoCare

October 8, 2025

·

2 min read

·

Tristan Manalac

Podcast

Shutdown Pauses New Drug Reviews, CDC Issues New COVID Guidance, CGT Meets on Mesa

October 8, 2025

·

1 min read

·

Heather McKenzie